Human ErbB3 / Her3 Protein, His Tag (MALS verified)
分子別名(Synonym)
ERBB3,HER3,LCCS2,MDA-BF-1,MGC88033,c-erbB3,erbB3-S,p180-ErbB3,p45-sErbB3,p85-sErbB3
表達區(qū)間及表達系統(tǒng)(Source)
Human ErbB3, His Tag (ER3-H5223) is expressed from human 293 cells (HEK293). It contains AA Ser 20 - Thr 643 (Accession # P21860-1).
Predicted N-terminus: Ser 20
蛋白結(jié)構(gòu)(Molecular Characterization)

This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 70.5 kDa. The protein migrates as 70-80 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 0.1 EU per μg by the LAL method / rFC method.
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.


背景介紹
ErbB3(亦稱Her3,即人表皮生長因子受體3)是表皮生長因子受體(EGFR)家族中的受體酪氨酸激酶成員。這種膜結(jié)合糖蛋白雖具有神經(jīng)調(diào)節(jié)蛋白結(jié)合結(jié)構(gòu)域,但其激酶結(jié)構(gòu)域不具備活性功能。因此它能結(jié)合配體,卻無法通過蛋白質(zhì)磷酸化介導細胞內(nèi)信號轉(zhuǎn)導。然而,ErbB3可與ErbB2或其他EGFR家族成員形成異源二聚體,由后者完成酪氨酸磷酸化過程,從而構(gòu)建有功能的受體復合體并激活相關(guān)通路,最終引發(fā)細胞增殖或分化。該蛋白在前列腺癌、膀胱癌及乳腺癌等多種惡性腫瘤中均存在過表達現(xiàn)象。通過選擇性剪接可產(chǎn)生不同亞型,其中缺乏跨膜區(qū)的分泌型異構(gòu)體能調(diào)節(jié)膜結(jié)合型受體的活性。
關(guān)鍵字: ErbB3;ErbB3蛋白;ErbB3重組蛋白;ACRO;百普賽斯;
百普賽斯集團ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團業(yè)務遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學等。